re: Ann: Pharmaxis Announces Two Board Retire...
I actually think the company has gone about things methodically and sensibly in the last 4-6 months.
They have kept and incentivised key employees, shrunk the business without necessarily damaging the franchise, and set out a lower risk course (not that anything in this industry is risk free).
What has been completely forgotten is that the market opportunity in the US still exists. It's just been delayed. The upside might not be billions but it would certainly be many multiples of the current market cap if it comes off.
Plus the newer products that Wiijon refers to that have no value whatsoever ascribed to them.
The fact that index trackers are selling proves nothing.
I reserve the right to be disappointed, but from a 13-15c entry price, I am currently optimistic.
PXS Price at posting:
13.0¢ Sentiment: Buy Disclosure: Held
